Leaky gut: mechanisms, measurement and clinical implications in humansMichael Camilleri
10 May 2019
Messenger RNA therapy for rare genetic metabolic diseasesPedro Berraondo, Paolo G V Martini, Matias A Avila, Antonio Fontanellas
22 February 2019
Role of the microbiome in human developmentMaria Gloria Dominguez-Bello, Filipa Godoy-Vitorino, Rob Knight, Martin J Blaser
22 January 2019
Non-coding DNA in IBD: from sequence variation in DNA regulatory elements to novel therapeutic potentialClaartje Aleid Meddens, Amy Catharina Johanna van der List, Edward Eelco Salomon Nieuwenhuis, Michal Mokry
28 January 2019
Combating pancreatic cancer with PI3K pathway inhibitors in the era of personalised medicineJames RW Conway, David Herrmann, TR Jeffry Evans, Jennifer P Morton, Paul Timpson
5 November 2018
Tight junction proteins in gastrointestinal and liver diseaseMirjam B Zeisel, Punita Dhawan, Thomas F Baumert
8 October 2018
Small metabolites, possible big changes: a microbiota-centered view of non-alcoholic fatty liver diseaseHuikuan Chu, Yi Duan, Ling Yang, Bernd Schnabl
31 August 2018
Stromal biology and therapy in pancreatic cancer: ready for clinical translation?Albrecht Neesse, Christian Alexander Bauer, Daniel Öhlund, Matthias Lauth, Malte Buchholz, Patrick Michl, David A Tuveson, Thomas M Gress
3 September 2018
Liquid biopsy for liver diseasesJelena Mann, Helen L Reeves, Ariel E Feldstein
3 September 2018
Enterocolitis due to immune checkpoint inhibitors: a systematic reviewEmilie Soularue, Patricia Lepage, Jean Frederic Colombel, Clelia Coutzac, David Faleck, Lysiane Marthey, Michael Collins, Nathalie Chaput, Caroline Robert, Franck Carbonnel
21 August 2018